Related Experiment Videos
Myocardial perfusion imaging using technetium-99m radiopharmaceuticals
H Kiat1, D S Berman, J Maddahi
1Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California.
Radiologic Clinics of North America
|July 1, 1993
Summary
Nuclear cardiology advancements aid in detecting coronary artery disease and assessing its severity. Myocardial perfusion imaging is key for evaluating heart muscle health and predicting cardiac events.
Area of Science:
- Cardiovascular Imaging
- Nuclear Cardiology
- Diagnostic Medicine
Background:
- Nuclear cardiology has significantly advanced noninvasive diagnostic capabilities for coronary artery disease (CAD).
- Current research focuses on refining techniques for CAD detection, severity assessment, and cardiac event prognostication.
Purpose of the Study:
- To discuss the clinical applications of myocardial perfusion imaging (MPI).
- To describe established and emerging techniques for evaluating myocardial viability.
Main Methods:
- Review of current literature and clinical practices in nuclear cardiology.
- Detailed explanation of myocardial perfusion imaging protocols.
- Description of methods for assessing myocardial viability, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
Main Results:
- Myocardial perfusion imaging provides crucial data for diagnosing CAD.
- MPI effectively assesses the extent and severity of myocardial ischemia.
- Viability assessment using MPI aids in guiding therapeutic decisions and improving patient outcomes.
Conclusions:
- Nuclear cardiology, particularly MPI, is indispensable for the comprehensive management of coronary artery disease.
- Accurate assessment of myocardial perfusion and viability is essential for effective patient prognostication and treatment planning.